# Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin

> **NCT00196664** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 144 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT00196664
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2009-02
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2009-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196664, "Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00196664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*